BACT on London Stock Exchange

Syncona

Logo: synconaltd.com3

British investment trust

Syncona (LSE: SYNC) is a large British closed-ended investment trust dedicated to life science investments. Co-founded as Syncona Partners in 2012 by former CEO Martin Murphy and the Wellcome Trust, before merging with the Battle Against Cancer Investment Trust ('BACIT') in December 2016 and listing publicly, the company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.2 From Wikipedia, CC BY-SA 4.0

Price unavailable

Last updated Oct 16, 2026.

Overview

Aug 14, 2012Founded1

Compare with another stock.

See how the biggest companies compare on our leaderboards

Syncona image from its website
Image: synconaltd.com3

Syncona (LSE: SYNC) is a large British closed-ended investment trust dedicated to life science investments. Co-founded as Syncona Partners in 2012 by former CEO Martin Murphy and the Wellcome Trust, before merging with the Battle Against Cancer Investment Trust ('BACIT') in December 2016 and listing publicly, the company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Its Chair is Melanie Gee.2

Timeline

  1. Aug 14, 2012Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
    Company websiteSyncona logo